Larimar Therapeutics, Inc.(LRMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LRMR Larimar Therapeutics, Inc.

Trading 02-26 14:29:50 EST

5.45

-0.50

-8.49%

High5.76	Low5.20	Vol9.98M
Open5.38	D1 Closing5.95	Amplitude9.41%
Mkt Cap466.04M	Tradable Cap245.84M	Total Shares85.59M
T/O54.49M	T/O Rate22.11%	Tradable Shares45.15M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LRMR","market":"US","secType":"STK","nameCN":"Larimar Therapeutics, Inc.","latestPrice":5.445,"timestamp":1772134189720,"preClose":5.95,"halted":0,"volume":9983562,"delay":0,"changeRate":-0.08487394957983191,"floatShares":45149399,"shares":85590400,"eps":-1.953372,"marketStatus":"Trading","change":-0.505,"latestTime":"02-26 14:29:50 EST","open":5.38,"high":5.76,"low":5.2,"amount":54487685.66988,"amplitude":0.094118,"askPrice":5.45,"askSize":1327,"bidPrice":5.44,"bidSize":1500,"shortable":0,"etf":0,"ttmEps":-1.953372,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1772139600000},"marketStatusCode":2,"adr":0,"listingDate":1403150400000,"exchange":"NASDAQ","adjPreClose":5.95,"preHourTrading":{"tag":"盘前","latestPrice":5.38,"preClose":5.95,"latestTime":"09:29 EST","volume":895472,"amount":4915612.056048,"timestamp":1772116199999,"change":-0.57,"changeRate":-0.095798,"amplitude":0.119328},"postHourTrading":{"tag":"盘后","latestPrice":5.9515,"preClose":5.95,"latestTime":"19:59 EST","volume":1818329,"amount":10433800.8437,"timestamp":1772067596120,"change":0.0015,"changeRate":0.000252,"amplitude":0.112605},"volumeRatio":0.421701,"impliedVol":1.3317,"impliedVolPercentile":0.3386},"requestUrl":"/m/hq/s/LRMR/tweets","defaultTab":"tweets","newsList":[{"id":"2614426620","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2614426620","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614426620?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:22","pubTimestamp":1772112120,"startTime":"0","endTime":"0","summary":"Procept BioRobotics  shares were down 24% in recent Thursday premarket activity, a day after the company posted a wider Q4 net loss and BofA Securities downgraded the company's stock to underperform from neutral.The Trade Desk  stock was down 17%, a day after the company issued lower-than-expected Q1 revenue guidance.Vir Biotechnology  shares were 16% lower after the company said overnight it priced an underwritten offering of about 17.6 million of its common shares for expected gross proceeds of $150 million.Larimar Therapeutics  stock was down 11%, a day after the company said it priced an upsized public offering of 20 million common shares at $5 each to raise $100 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU1548497426.USD","LU1720051017.SGD","BK4548","BK4023","BK4535","LU2357305700.SGD","LU0348723411.USD","LU2324357040.USD","BK4588","TTD","BK4568","BK4082","BK4613","LU1720051108.HKD","TTDU","LRMR","BK4528","BK4139","VIR","BK4009","PRCT"],"gpt_icon":1},{"id":"2614616400","title":"Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2614616400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614616400?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:59","pubTimestamp":1772071187,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA62RBQK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LRMR"],"gpt_icon":0},{"id":"2614061647","title":"Larimar Therapeutics Inc - Prices Upsized Public Offering at $5.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2614061647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614061647?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:59","pubTimestamp":1772071187,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA62RBQK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LRMR"],"gpt_icon":0},{"id":"2614059270","title":"BUZZ-Larimar Therapeutics slips after $75 mln stock offering commenced","url":"https://stock-news.laohu8.com/highlight/detail?id=2614059270","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614059270?lang=en_us&edition=fundamental","pubTime":"2026-02-26 05:25","pubTimestamp":1772054735,"startTime":"0","endTime":"0","summary":"** Larimar Therapeutics LRMR.O shares down 5.4% at $5.63. in extended trading as it seeks equity raise after seeing its stock more than double in the past two sessions. ** LRMR shares finished up 61.2% at $5.95 on Weds following 31% surge on Tues after the U.S. FDA granted 'breakthrough' tag for co's neurological disorder therapy, nomlabofusp. ** Bala Cynwyd, Pennsylvania-based firm after the bell commences $75 mln offering comprising shares and pre-funded warrants. ** Co intends to use net offering proceeds to support development of nomlabofusp and for working capital and general corporate purposes, including R&D and commercialization expenses** JP Morgan and Guggenheim joint bookrunners** Co has ~83 mln shares outstanding for roughly $500 mln market cap, per LSEG. ** All 11 analysts are bullish including 7 \"strong buy\" ratings; median PT $16","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL6N3ZL1AM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051108.HKD","IE00BBT3K403.USD","LU0689472784.USD","IE0034235295.USD","IE00B1BXHZ80.USD","BK4533","BK4207","LU1496350502.SGD","LU1670628061.USD","LU0976567544.SGD","LU1162221912.USD","LU1894683264.USD","LU2242649171.HKD","LU1551013425.SGD","LU2106854487.HKD","IE00BJTD4N35.SGD","LU0070302665.USD","JPMO","BK4581","LU0787776722.HKD","LU0238689110.USD","BK4534","LU0215105999.USD","LU0820561909.HKD","LU2746668461.USD","LU2746668974.SGD","LU2237443622.USD","LU0170899867.USD","LU0943347566.SGD","LU2054465674.USD","LU1914381329.SGD","LRMR","LU0820562030.AUD","BK4139","LU2756315318.SGD","BK4516","LU0345770993.USD","LU2552382132.HKD","LU2552382058.USD","BK4550","LU0006306889.USD","LU2023250843.SGD","LU0320765646.SGD","LU2264538146.SGD","LU1116320737.USD","LU0265550359.USD","LU2417539215.USD","LU0323591593.USD","LU1267930490.SGD","LU1551013342.USD"],"gpt_icon":0},{"id":"2614205597","title":"Press Release: Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2614205597","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614205597?lang=en_us&edition=fundamental","pubTime":"2026-02-26 05:01","pubTimestamp":1772053260,"startTime":"0","endTime":"0","summary":"BALA CYNWYD, Pa., Feb. 25, 2026  -- Larimar Therapeutics, Inc.  , a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an underwritten public offering of $75 million of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. In addition, Larimar expects to grant the underwriters a 30-day option to purchase up to an additional $11.25 million of the securities to be sold in the proposed offering at the public offering price, less underwriting discounts and commissions. All shares of common stock and pre-funded warrants in the proposed offering are to be sold by Larimar. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the proposed offering.J.P. Morgan and Guggenheim Securities are a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LRMR","BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2614058291","title":"Laminar Therapeutics Stock Is Popping Today: What's Going On?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614058291","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614058291?lang=en_us&edition=fundamental","pubTime":"2026-02-26 03:30","pubTimestamp":1772047800,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics Inc (NASDAQ:LRMR) shares are soaring on Wednesday after multiple analysts reiterated their bullish outlook.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/25/Candlestick-Graph-Chart-Of-Stock-And-For_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/25/Candlestick-Graph-Chart-Of-Stock-And-For_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50864109/laminar-therapeutics-stock-is-popping-today-whats-going-on","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50864109/laminar-therapeutics-stock-is-popping-today-whats-going-on","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4539","BK4007","BK4139","LRMR","LENZ"],"gpt_icon":0},{"id":"2614058682","title":"Larimar Therapeutics Up Over 64%, on Pace for Largest Percent Increase Since January 2016 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2614058682","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614058682?lang=en_us&edition=fundamental","pubTime":"2026-02-26 03:10","pubTimestamp":1772046600,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics, Inc.  is currently at $6.06, up $2.37 or 64.23%. --Would be highest close since Dec. 13, 2024, when it closed at $6.17. --On pace for largest percent increase since Jan. 20, 2016, when it rose 78.65%. --Currently up two consecutive days; up 115.66% over this period. --Up 71.19% month-to-date; on pace for best month since Feb. 2024, when it rose 98.62%. --Down 99.02% from its all-time closing high of $616.08 on March 19, 2015. --Up 106.83% from 52 weeks ago , when it closed at $2.93. --Up 254.39% from its 52-week closing low of $1.71 on April 8, 2025. --Traded as high as $6.42; highest intraday level since Dec. 12, 2024, when it hit $6.48","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","BK4007","BK4539","LRMR"],"gpt_icon":0},{"id":"2614296347","title":"NASD Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2614296347","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614296347?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:43","pubTimestamp":1771972980,"startTime":"0","endTime":"0","summary":"Advanced Micro Devices       AMD    81,077,468    213.84    17.24      8.77. ProShares UltraPro QQQ      TQQQ    70,285,662     49.78     1.54      3.19. Defiance Dly Tgt 2x Lg      MSTX    67,759,131      2.10     0.02      0.96. GrShr 2x Sh NVDA Daily       NVD    66,192,781      6.44    -0.08     -1.23. American Airlines Group      AAL    64,450,342     13.15     0.22      1.70. Direxion Dly TSLA Br 1X     TSLS    59,296,289      5.54    -0.14     -2.46. Direxion TSLA Bull 2X       TSLL    55,847,376     15.25     0.72      4.96. Invesco QQQ Trust I          QQQ    54,690,802    607.87     6.46      1.07. Defiance Tgt 2X Lg HIMS     HIMZ    50,186,252      1.11    -0.02     -1.77. Elong Power Holding         ELPW    49,769,025    0.4182     0.03      7.23","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210528500.USD","BK4566","BK4543","LU1923622291.USD","LU0109391861.USD","LU1720051017.SGD","SG9999017495.SGD","LU0640476718.USD","LU1116320737.USD","LU2087625088.SGD","TSLA","LU2065171311.SGD","LU2381873111.SGD","LU0157215616.USD","LU2491050071.SGD","AMDD","LU2471134523.USD","LU0345770308.USD","LU0081259029.USD","LU1496350502.SGD","TSLY","LU0006306889.USD","IE00BQXX3D17.EUR","HK0000320264.USD","LU1674673428.USD","LU0265550946.USD","LU2552382058.USD","LU1261432733.SGD","LU2931357623.SGD","LU1992135472.HKD","SG9999014914.USD","BK4512","NVDA","LU0820561818.USD","LU0210533765.USD","LU0274383776.USD","LU0048584097.USD","LU2746668974.SGD","LU1366333091.USD","HK0000306701.USD","LU0158827948.USD","LU0265550359.USD","LU2473716301.USD","LU2322448791.USD","IE0034235303.USD","AALG","BK4141","SG9999004303.SGD","IE0009G5SDU7.USD","LRMR","LU2430703095.HKD","NVD3.UK","LU1974910355.USD","LU1934455277.USD","LU2360032135.SGD","LU0256863811.USD","AMYY","LU0348723411.USD","LU1935043023.USD","TSII","LU0225283273.USD","LU1917777945.USD","IE00B3SWFQ91.USD","LU2272731600.USD","LU0354030511.USD","BK4532","LU2087621335.USD","LU2237957811.SGD","LU2023250504.SGD","LU2168563687.JPY","LU1852331112.SGD","LU0823421333.USD","LU0965509010.AUD","LU0061474960.USD","SG9999015945.SGD","BK4592","BK4515","SGXZ51526630.SGD","LU2491049909.HKD","LU2272731865.HKD","TSLG","AMDG","LU2286300806.USD","LU2896262040.SGD","LU1066051498.USD","LU1066051811.HKD","LU1551013425.SGD","IE00BJTD4N35.SGD","LU1721428933.USD","LU1633808545.USD","LU2168564222.USD","IE00BD6J9T35.USD","LU0672654240.SGD","SG9999002224.SGD","LU2430703251.USD","LU2543165471.USD","LU0823421416.USD","AMDY","LU2125909593.SGD","TSLZ","LU1323610961.USD","LU1880398471.USD","LU1069344957.HKD","LU2505996509.AUD","NVDY","LU0345768740.USD","LU2097344357.USD","LU2098885051.SGD","LU2322448957.HKD","LU1821325948.USD","LU0011850046.USD","LU2272731782.SGD","IE00B3M56506.USD","LU2250418816.HKD","LU1989772923.USD","BK4588","LU1267930730.SGD","LU0965509283.SGD","BK4573","LU0203201768.USD","LU0476273544.USD","LU0256863902.USD","LU2420271590.USD","LU0106261372.USD","LU1951200564.SGD","LU2357125470.USD","NVD2.UK","LU1691799644.USD","LU1127390331.HKD","LU1242518857.USD","LU1366192091.USD","LU2242650005.HKD","IE00BMPRXQ63.HKD","LU0267386448.USD","BK4567","SGXZ99366536.SGD","LINT","LU0094547139.USD","NVDB","IE00BJJMRY28.SGD","ANV","LU1064131342.USD","LU2403377893.USD","LU0316494557.USD","NVDU","LU2089284900.SGD","LU0417517546.SGD","IE0004445239.USD","LU2083900584.USD","NVDQ","TLA","SG9999014575.USD","SG9999018865.SGD","LU0823414478.USD","LU0321505439.SGD","LU0234572021.USD","LU1623119135.USD","LU2242649171.HKD","IE00B775SV38.USD","NVDS.UK","LU0823434583.USD","LU0345769631.USD","LU0215105999.USD","LU2054465674.USD","LU2458330243.SGD","LU0689626769.HKD","NVDG","LU2361044949.HKD","LU2471134879.HKD","TSYY","IE00BZ1G4Q59.USD","LU2360106780.USD","AMDW","LU1839511570.USD","LU0444973449.USD","IE0009356076.USD","LU1084165304.USD","LU0964807845.USD","LU0096364046.USD","LU2413666426.HKD","LU2065169927.USD","BK4587","SG9999015358.SGD","IE00B4YYXB79.USD","BK4602","IE00BJTD4V19.USD","LU0444971666.USD","LU2213496289.HKD","LU0347712357.USD","INTW","IE00BQXX3C00.GBP","LU2487616109.SGD","LU2249611893.SGD","LU0154236417.USD","LU2746668461.USD","SG9999015341.SGD","LU1804176565.USD","BK4549","BK4511","LU2168564065.EUR","LU1244550494.USD","LU2360107168.USD","LU0820562030.AUD","IE000KEQY171.SGD","LU2552382132.HKD","IE00B775H168.HKD","LU0056508442.USD","IE00B19Z8X17.USD","LU0061474705.USD","LU2756315318.SGD","BK4503","SG9999015952.SGD","LU0868494708.USD","LU1066053197.SGD","LU0211327993.USD","SG9999014542.SGD","IE0004445015.USD","IE00BN29S564.USD","LU0061475181.USD","LU0511384066.AUD","LU1496350171.SGD","LU0965508806.USD","LU0276348264.USD","BK4574","ELPW","LU2125909759.SGD","LU0390134368.USD","LU2592432038.USD","LU2168564495.EUR","TSDD","LU0823434740.USD","LU0354030438.USD","NVDS","LU1815336760.USD","LU2361045086.USD","LU2106854487.HKD","BK4516","LU1037948541.HKD","LU2463028550.USD","IE0004091025.USD","LU1778281490.HKD","LU1861215975.USD","IE00BK4W5M84.HKD","LU1934455194.USD","LU2191332357.HKD","LU1992135399.USD","LU0096362180.USD","LU2413666699.HKD","LU1066051225.USD","IE00BDCRKT87.USD","LU2361044865.SGD","LU1914381329.SGD","LU2491050154.USD","LU0345770993.USD","LU0342679015.USD","LU0642271901.SGD","IE0004086264.USD","LU0861579265.USD","LU2750360997.AUD","LU2125154935.USD","04335","BK4555","LU2357305700.SGD","LU2433249047.HKD","GB00BDT5M118.USD","NVDW","LU2125154778.USD","GOSS","LU1037948897.HKD","LU1803068979.SGD","TSLR","LU1989764664.SGD","LU0107464264.USD","LU0251132253.USD","CIFR","LU2756315664.SGD","SG9999018857.SGD","MSTX","LU0345769128.USD","IE00BQXX3F31.USD","BK4581","LU0211328371.USD","LU0175139822.USD","IE0005OL40V9.USD","CRSH","LU0109392836.USD","LU0124676726.USD","LU1551013342.USD","LU2089283258.USD","BK4604","IE0001KFT4U8.USD","LU0979878070.USD","BK4554","LU0170899867.USD","LU1720051108.HKD","BK4548","PYPL","LU1983260115.SGD","LU1718418525.SGD","SG9999014559.SGD","LU0057025933.USD","LU0985320562.USD","AMUU","TSLI","2NVD.UK","LU1153585028.USD","BK4575","HK0000306685.HKD","LU2355687059.USD","LU0203202063.USD","TSL","SG9999014567.USD","LU1988902786.USD","TEST","LU0689472784.USD","BK4527","LU1868837136.USD","LU2111349929.HKD","LU2265009873.SGD","LU0128525929.USD","LU2244417387.USD","LU1861558580.USD","LU1712237335.SGD","IE0034235295.USD","IE00BFSS8Q28.SGD","LU0069063385.USD","LU0353189680.USD","LU2506951792.HKD","SG9999015986.USD","LU1642822529.SGD","LU0289961442.SGD","IE00BKPKM429.USD","LU2602419157.SGD","LU0943347566.SGD","LU1861127337.USD","IE00BYXW3230.USD","LU0308772762.SGD","BK4099","LU2326559502.SGD","LU0310799852.SGD","LU0082616367.USD","LU1935042215.USD","LU1880398554.USD","LU0321505868.SGD","IE00B7KXQ091.USD","LU2471134952.CNY","IE00BHPRN162.USD","BK4534","LU0889565833.HKD","SGXZ23171101.USD","LU2023251221.USD","BK4550","NVII","LU2247934214.USD","INTC","LU1791710582.SGD","LU2294711713.HKD","LU1244550221.USD","LU2092627202.USD","IOVA","IE00B19Z8W00.USD","LU1951198990.SGD","BK4598","LU0345768153.USD","SG9999014880.SGD","LU0289960550.SGD","NVDD","HK0000914686.HKD","LU0029864427.USD","LU0708994859.HKD","LU1815333072.USD","BK4593","LU0942090050.USD","LU2461242641.AUD","LU2097344431.USD","LU2237957902.USD","LU2237438978.USD","IE00BKDWB100.SGD","LU1814569148.SGD","BK4008","BK4585","BK4551","LU1868836914.USD","LU0882574139.USD","IE00BJLML261.HKD","SGXZ31699556.SGD","LU2264538146.SGD","TSLP","LU0080751232.USD","BK4529","LU2089985449.USD","LU2462157665.USD","SG9999015978.USD","LU2168564149.EUR","LU2125909916.SGD","LU2430703178.SGD","LU0097036916.USD","LU0719512351.SGD","BK4579","TSLQ","LU1868836591.USD","BK4547","IE00B3S45H60.SGD","LU2148611432.USD","LU2028103732.USD","NVIW.SI","LU1923622614.USD","LU2023250330.USD","LU1935042991.SGD","LU2456880835.USD","LU0528227936.USD","LU2505996681.GBP","TSLS","SG9999000418.SGD","LU1429558221.USD","LU0070217475.USD","BK4614","LU1868836757.USD","BK4608","SNVD.UK","TQQQ","LU1267930573.SGD","LU1316542783.SGD","LU2458330169.SGD","LU0868494617.USD","LU0077335932.USD","AAL","LU2092937148.SGD","IE000M9KFDE8.USD","DAMD","LU2750360641.GBP","LU1923623000.USD","IE00BMPRXR70.SGD","IE00BZ199S13.USD","IE0003U64NQ7.SGD","IE00BDRTCR15.USD","LU0320765059.SGD","IE00B4JS1V06.HKD","TSLW","LU0708995401.HKD","07766","LU0158827781.USD","LU1868837300.USD","HIMZ","SGXZ81514606.USD","LU1989772840.SGD","LU0289739343.SGD","LU1119994496.HKD","LU1244550577.SGD","LU0210536198.USD","SG9999002232.USD","IE000ITXATA3.USD","BK4605","LU2063271972.USD","LU2211815571.USD","LU2236285917.USD","LU2471134796.USD","AMD","LU0466842654.USD","LU0323591593.USD","HK0000914660.USD","LU1861220033.SGD","LU1548497426.USD","LU0127658192.USD","LU1571399168.USD","LU2108987350.USD","TSLO","IE00BMPRXN33.USD","IE00BSNM7G36.USD","IE0034235188.USD","IE000W1ABFV2.USD","IE00B1BXHZ80.USD","LU0724617625.USD","LU1116320901.HKD","NVD","LU0072462426.USD","AMDU","LU2271345857.HKD","IE00BJJMRX11.SGD","LU2417539215.USD","LU0965509101.SGD","LU2860962120.EUR","SG9999014898.SGD","TESL","LU0683600562.USD","LU2065170008.USD","3NVD.UK","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","QQQI","LU0957808578.USD","LU1791710400.SGD","SG9999014906.USD","LU2065171402.SGD","LU1035775433.USD","DIPS","LU0786609619.USD","LU0198837287.USD","IE000YTNTUN2.SGD","LU0310800379.SGD","IE00B5949003.HKD","NVDX","LU1242518931.SGD","LU1989764748.USD","LU0053666078.USD","LU0788109477.HKD","LU0187121727.USD","LU1280957306.USD","LU1145028129.USD","LU1629891620.HKD","LU1861559042.SGD","LU0820561909.HKD","HK0000320223.HKD","LU1303367103.USD","LU1699723380.USD","BK4612","SG9999001424.SGD","BK4561","LU0238689110.USD","LU1935042488.USD","LU2125909247.SGD","TSLL","LU0823414551.USD","IE00BKVL7J92.USD","LU2290526834.HKD","LU0494093205.USD","LU1934455863.HKD","BK4533","LU0234570918.USD","TSLT","LU0957791311.USD","BK4500","LU2452424414.USD","IE00BK4W5L77.USD","LU1935043536.SGD","IE00B1XK9C88.USD","LU0079474960.USD","LU0266013472.USD","BK4535","LU0353189763.USD","LU1435385759.SGD","LU0472753341.HKD","LU1232071149.USD","IE00B19Z9505.USD","LU1267930490.SGD","LU1674673691.USD","LU2552382215.SGD","LU0823411888.USD","LU2077746001.SGD","LU0787776722.HKD","LU0557290698.USD"],"gpt_icon":1},{"id":"2614847746","title":"Larimar Therapeutics Up Nearly 32%, on Pace for Largest Percent Increase Since February 2024 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2614847746","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614847746?lang=en_us&edition=fundamental","pubTime":"2026-02-25 00:39","pubTimestamp":1771951140,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics, Inc.  is currently at $3.70, up $0.89 or 31.78%. --Would be highest close since Dec. 31, 2025, when it closed at $3.81. --On pace for largest percent increase since Feb. 14, 2024, when it rose 36.84%. --Up 4.61% month-to-date; on pace for best month since Dec. 2025, when it rose 7.63%. --Down 99.4% from its all-time closing high of $616.08 on March 19, 2015. --Up 116.56% from its 52-week closing low of $1.71 on April 8, 2025. --Traded as high as $4.01; highest intraday level since Dec. 24, 2025, when it hit $4.04","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","LENZ","BK4007","LRMR"],"gpt_icon":0},{"id":"2613745858","title":"BUZZ-U.S. STOCKS ON THE MOVE-Henry Schein, Domino's Pizza, FactSet","url":"https://stock-news.laohu8.com/highlight/detail?id=2613745858","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613745858?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:55","pubTimestamp":1771948559,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Henry Schein, Domino's Pizza, FactSetEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL6N3ZK170:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSIC","ANPA","KDP","DPZ","ED","LRMR","NEMG","SHLS","THR","VIR","FGL","CLVT","AES","ROAD","WHR","ELAN","TNC","AWI","KTOS","EXPD","KEYS","SEG","ITRI","OKE","HIMZ","AMYY","CNP","FDS","AU","CVS","PPL","FRPT","PVLA","HD","AMDD","ALUR","OWL","NRG","TARA","ELIS","HMYY","BOOM"],"gpt_icon":1},{"id":"2613179777","title":"BUZZ-U.S. STOCKS ON THE MOVE-Advanced Micro Devices, Constellation Energy, NRG Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2613179777","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613179777?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:12","pubTimestamp":1771942333,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Advanced Micro Devices, Constellation Energy, NRG EnergyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL6N3ZK0O3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIL","LLYX","BEX","HIMZ","KEYS","AES","ROAD","AMDY","AMDU","CEGX","NWMX","WHR","KTUP","AMDW","LRMR","NRG","BEZ","HIYY","AMUU","VIR","BEG","AWI","HD","RJF","KDP","AMDG","PPL","OWL","THR","GPC","KTOS","CEG","AMDD","ELIS","FRPT","DAMD","HIMY","AMYY","AU","AMD","NEMG","LLYZ","HMYY","PVLA"],"gpt_icon":1},{"id":"2613086714","title":"Larimar Therapeutics Shares up 35.6% Premarket on FDA's 'Breakthrough' Tag for Neurological Disorder Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2613086714","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613086714?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:34","pubTimestamp":1771940060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK0OK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LRMR"],"gpt_icon":0},{"id":"2613714076","title":"BUZZ-Larimar jumps on FDA's 'breakthrough' tag for neurological disorder therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714076","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613714076?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:34","pubTimestamp":1771940058,"startTime":"0","endTime":"0","summary":"BUZZ-Larimar jumps on FDA's 'breakthrough' tag for neurological disorder therapy** Shares of therapy developer Larimar Therapeutics LRMR.O jump 32% to $3.71 premarket** Co says the U.S. FDA granted a breakthrough designation for its experimental therapy nomlabofusp** A breakthrough therapy tag is meant to speed up development and review of drugs to treat a serious condition or unmet medical need** Nomlabofusp is a protein replacement therapy for the treatment of adults and children with the neurodegenerative disorder, Friedreich's ataxia** Co plans to submit marketing application for nomlabofusp by June** Up to last close, stock down 26.3% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4N3ZK19H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LRMR"],"gpt_icon":0},{"id":"2613719522","title":"Larimar Shares Jump Premarket on Breakthrough Therapy Designation for Lead Compound","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719522","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719522?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:37","pubTimestamp":1771936620,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics' shares rallied ahead of the opening bell after the biotechnology company's lead compound received breakthrough therapy designation from the Food and Drug Administration.In premarket trading, the shares were 29% higher at $3.63. The stock had been down so far in February, and had lost 23% over the last three months.Larimar on Tuesday said nomlabofusp, a protein replacement therapy that is being developed as a potential treatment for Friedreich's ataxia, was granted the important designation that is designed to expedite the development and regulatory review of drugs targeting serious conditions.The company said breakthrough therapy designation and FDA feedback on its submission were based on the regulator's review of available clinical data from an ongoing open label study evaluating nomlabofusp in adult and pediatric patients with Friedreich's ataxia.Larimar is targeting a biologics license application submission in June, backed by topline open-label study data tha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Larimar Shares Jump Premarket on Breakthrough Therapy Designation for Lead Compound","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LRMR"],"gpt_icon":0},{"id":"2613471626","title":"Larimar Therapeutics Announces FDA Breakthrough Therapy Designation For Nomlabofusp","url":"https://stock-news.laohu8.com/highlight/detail?id=2613471626","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613471626?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:25","pubTimestamp":1771935955,"startTime":"0","endTime":"0","summary":"Feb 24 (Reuters) - Larimar Therapeutics Inc ::*LARIMAR THERAPEUTICS ANNOUNCES FDA BREAKTHROUGH THERAPY DESIGNATION FOR NOMLABOFUSP IN FA AND REITERATES PLANNED BLA SUBMISSION IN JUNE 2026  ((Reuters I","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nRSDc7Nw2x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LRMR","BK4139"],"gpt_icon":0},{"id":"2613715448","title":"FDA grants Breakthrough Therapy Designation to Larimar’s nomlabofusp for Friedreich’s ataxia","url":"https://stock-news.laohu8.com/highlight/detail?id=2613715448","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613715448?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:03","pubTimestamp":1771934625,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics said the FDA granted Breakthrough Therapy Designation to nomlabofusp for the treatment of adults and children with Friedreich's ataxia. The company also reported that FDA written communications following a START meeting continued to align with using skin frataxin  as a surrogate endpoint to support a planned biologics license application seeking accelerated approval, which Larimar said remains on track for submission in June 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL5bpSzc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4588","LRMR","BK4585","BK4139","BK4112","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014005.SGD","LU2210149790.SGD","NDAQ","LU2210150020.SGD","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","SG9999014021.USD"],"gpt_icon":0},{"id":"2613715314","title":"Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in Fa and Reiterates Planned Bla Submission in June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613715314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613715314?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934405,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUA2KWZ2M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LRMR"],"gpt_icon":0},{"id":"2592990919","title":"Larimar Therapeutics Swaps Common Shares for Series A Convertible Preferred Stock in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2592990919","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592990919?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:01","pubTimestamp":1765976508,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics Inc. announced that it has entered into an exchange agreement with Blue Owl Healthcare Opportunities IV Public Investments LP. Under the agreement, Blue Owl exchanged 2,500,000 shares of Larimar's common stock for 250,000 shares of newly designated Series A convertible preferred stock. The preferred stock, described as \"toothless,\" is convertible into common stock at a ratio of 1-to-10, subject to certain ownership limits. The transaction was completed as an unregistered sale, relying on the exemption from registration provided by Section 3 of the Securities Act.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Larimar Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the El","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL3fZs94:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","IE00BLSP4239.USD","LRMR","IE00BLSP4452.SGD","OWL","BK4139","IE00BBT3K403.USD","IE00BN8TJ469.HKD"],"gpt_icon":0},{"id":"2584926815","title":"Larimar Therapeutics Q3 Net Income USD -47.712 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584926815","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584926815?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:38","pubTimestamp":1763570317,"startTime":"0","endTime":"0","summary":"Nov 05 (Reuters) - Larimar Therapeutics Q3 operating expenses USD 49.499 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 05-NOV-202512:00:50.457 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD9Y0qxd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LRMR"],"gpt_icon":0},{"id":"2581095673","title":"Analysts Offer Insights on Healthcare Companies: Radnet (RDNT), Palvella Therapeutics (PVLA) and Larimar Therapeutics (LRMR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581095673","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581095673?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:10","pubTimestamp":1762434619,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Radnet (RDNT – Research Report), Palvella Therapeuti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-radnet-rdnt-palvella-therapeutics-pvla-and-larimar-therapeutics-lrmr-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-radnet-rdnt-palvella-therapeutics-pvla-and-larimar-therapeutics-lrmr-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU2065731478.USD","BK4196","RDNT","BK4588","BK4139","XLV","BK4581","BK4585","XBI","LU0029874061.USD","BK4137","LABU","LRMR","PVLA","HCSG"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.larimartx.com","stockEarnings":[{"period":"1week","weight":1.0169},{"period":"1month","weight":0.6528},{"period":"3month","weight":0.6856},{"period":"6month","weight":0.6436},{"period":"1year","weight":1.0169},{"period":"ytd","weight":0.5617}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.088036},{"month":2,"riseRate":0.583333,"avgChangeRate":0.10518},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.145103},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.028256},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.091938},{"month":6,"riseRate":0.545455,"avgChangeRate":0.006336},{"month":7,"riseRate":0.5,"avgChangeRate":-0.021968},{"month":8,"riseRate":0.5,"avgChangeRate":0.081374},{"month":9,"riseRate":0.416667,"avgChangeRate":0.000938},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.029427},{"month":11,"riseRate":0.583333,"avgChangeRate":0.038429},{"month":12,"riseRate":0.583333,"avgChangeRate":0.050649}],"exchange":"NASDAQ","name":"Larimar Therapeutics, Inc.","nameEN":"Larimar Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Larimar Therapeutics, Inc.(LRMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Larimar Therapeutics, Inc.(LRMR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Larimar Therapeutics, Inc.,LRMR,Larimar Therapeutics, Inc.股票,Larimar Therapeutics, Inc.股票老虎,Larimar Therapeutics, Inc.股票老虎国际,Larimar Therapeutics, Inc.行情,Larimar Therapeutics, Inc.股票行情,Larimar Therapeutics, Inc.股价,Larimar Therapeutics, Inc.股市,Larimar Therapeutics, Inc.股票价格,Larimar Therapeutics, Inc.股票交易,Larimar Therapeutics, Inc.股票购买,Larimar Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Larimar Therapeutics, Inc.(LRMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Larimar Therapeutics, Inc.(LRMR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction